38 results
POS AM
ADIL
Adial Pharmaceuticals Inc
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
may result in unexpected costs, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics … with the Company’s Code of Business Conduct and Ethics, investigating alleged breaches or violations thereof and enforcing its provisions.
Special Committee
During
POS AM
jqkh4jzy
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
POS AM
kvbbdczlf xxsr
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
3il4x45gz23f0xm8
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
424B3
ulcl0q oldlx8l
13 Jul 20
Prospectus supplement
4:46pm
8-K
EX-99.1
svq37xvjo6bglr62
11 Jun 20
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland
11:58am
424B5
a4qc1eaa6 typx2
10 Jun 20
Prospectus supplement for primary offering
4:14pm
424B3
as0dn46
22 May 20
Prospectus supplement
4:30pm
424B3
ikoayfydvhmnxq
22 May 20
Prospectus supplement
4:28pm